Video Preview: http://youtu.be/c-Ht8nyohCM
Extraordinary advancements in mobile technology and connectivity over the last several decades have provided the foundation needed to dramatically change the way healthcare is currently practiced. While the utilization of mobile telecommunication technologies for the delivery of healthcare (mobile, or mHealth), is still in its earliest stages of development, the evidence supporting its potential to impact the delivery of care, to improve outcomes and lower costs is evident. For healthcare consumers, mHealth technologies can allow for the more convenient, rapid and personalized diagnosis of some of the most common acute symptomatic illnesses; for example upper respiratory tract infections, urinary tract infections, otitis media in children and dizziness/syncope. In individuals with chronic medical conditions, who account for nearly 90% of healthcare spending, mHealth technologies can transform their care through improved monitoring, tracking, and engagement of critical biometrics during routine daily activities, not only in doctor’s offices. While the overall goal of mobile health solutions in the out-patient setting is to greatly empower patients to better care for themselves in conjunction with their healthcare provider, rather than damaging the doctor-patient relationship this transformation in care will instead reinforce that relationship in allowing physicians to re-establish their role as diagnostician and educator for their patients. mHealth technologies have the potential to dramatically change every aspect of the healthcare environment and to do so while delivering better outcomes and substantially lowering costs. Most critical to driving this transformation is the need for real-world clinical trial evidence of the overall benefit of mHealth to the patient and the healthcare system.
Dr Steinhubl is the Director of Digital Medicine at the Scripps Translational Science Institute and a clinical cardiologist at Scripps Health. He received his undergraduate training in chemical engineering at Purdue University in Indiana, graduate training in physiology at Georgetown University in Washington, DC, and his medical degree at St. Louis University in Missouri. Steve’s internal medicine residency training was completed at David Grant Medical Center at Travis Air Force Base, California. Following residency, he was a staff internist at Elmendorf Air Force Base Hospital in Anchorage, Alaska. His cardiology and interventional cardiology fellowships were at the Cleveland Clinic Foundation where he was also Chief Cardiology Fellow. Prior to joining Scripps Steve was the Director of Cardiovascular Wellness and the Medical Director for Employee Wellness for the Geisinger Healthcare System. He was also the Cardiology Fellowship Director, a clinician-scientist and a staff cardiologist there. In the past, beyond his time in the Air Force, Steve has also been a Global Medical Vice-President for The Medicines Company based in Zurich Switzerland and the Director of Cardiovascular Education and Clinical Research at the University of Kentucky in Lexington.
Dr Steinhubl’s research activities have covered a broad range of topics in cardiology with a primary early focus on trials of novel antithrombotic therapies for the treatment and prevention of cardiovascular disease, and more recently on the application of an integrated systems-based approach to the optimal identification, communication and treatment of an individual’s risk for various manifestations of cardiovascular disease. He has been principal investigator or helped lead over a dozen large-scale, international randomized trials and has authored over 180 peer-reviewed manuscripts as well as numerous book chapters, and abstracts.
5:30pm-6:45pm Networking ( Free appetizers and drinks )
6:45pm-7:00pm HTF Update
7:00pm-7:45pm Presentation: Mobile Health – An Evidence-Based Look Beyond the Hype
7:45pm-8:30pm Continued Networking / Meet Dr. Steinhubl